Literature DB >> 29617787

Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

A Clinton White1, Christina M Coyle2, Vedantam Rajshekhar3, Gagandeep Singh4, W Allen Hauser5, Aaron Mohanty1, Hector H Garcia6, Theodore E Nash7.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29617787      PMCID： PMC5889044          DOI： 10.1093/cid/ciy157

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  1 in total

1.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26
  1 in total
  15 in total

1.  Reply to Garg et al, Smith et al, and Persichino and Miller.

Authors:  A Clinton White; Christina M Coyle; Vedantam Rajshekhar; Gagandeep Singh; W Allen Hauser; Aaron Mohanty; Hector H Garcia; Theodore E Nash
Journal:  Clin Infect Dis       Date:  2018-11-13       Impact factor: 9.079

2.  A Personal Account Regarding the Origin and Evolution of Controversies in the Management of Neurocysticercosis.

Authors:  Oscar H Del Brutto
Journal:  Am J Trop Med Hyg       Date:  2019-04       Impact factor: 2.345

3.  A longitudinal analysis of albendazole treatment effect on neurocysticercosis cyst evolution using multistate models.

Authors:  Michelle A Montgomery; Marcel Ramos; Elizabeth A Kelvin; Arturo Carpio; Alexander Jaramillo; W Allen Hauser; Hongbin Zhang
Journal:  Trans R Soc Trop Med Hyg       Date:  2019-12-01       Impact factor: 2.184

4.  Intraventricular neurocysticercosis causing obstructing hydrocephalus.

Authors:  Alejandro Perez; Gaurav Syngal; Samreen Fathima; Sam Laali; Sadat Shamim
Journal:  Proc (Bayl Univ Med Cent)       Date:  2022-05-31

Review 5.  Taenia solium Cysticercosis and Its Impact in Neurological Disease.

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

6.  Comparison of complementary diagnostic tests in cerebrospinal fluid and serum for neurocysticercosis.

Authors:  Matthew L Romo; Arturo Carpio; R Michael E Parkhouse; María Milagros Cortéz; Richar Rodríguez-Hidalgo
Journal:  Heliyon       Date:  2018-12-01

7.  Clinicopathology conference: 41-year-old woman with chronic relapsing meningitis.

Authors:  Erin S Beck; Prashanth S Ramachandran; Lillian M Khan; Hannah A Sample; Kelsey C Zorn; Elise M O'Connell; Theodore Nash; Daniel S Reich; Arun Venkatesan; Joseph L DeRisi; Avindra Nath; Michael R Wilson
Journal:  Ann Neurol       Date:  2019-01-07       Impact factor: 10.422

8.  Next-generation sequencing combined with serological tests based pathogen analysis for a neurocysticercosis patient with a 20-year history:a case report.

Authors:  Bin Chen; Zheng Chen; Yi-Shu Yang; Gui-Lan Cai; Xiao-Jiao Xu; Hong-Zhi Guan; Hai-Tao Ren; Hou-Zhen Tuo
Journal:  BMC Neurol       Date:  2021-06-24       Impact factor: 2.474

Review 9.  Neurocysticercosis. A frequent cause of seizures, epilepsy, and other neurological morbidity in most of the world.

Authors:  J Bustos; I Gonzales; H Saavedra; S Handali; H H Garcia
Journal:  J Neurol Sci       Date:  2021-06-17       Impact factor: 4.553

10.  Lumbosacral Radiculopathy as the Clinical Presentation of Neurocysticercosis.

Authors:  María Asunción Pérez-Jacoiste Asín; Patricia Calleja-Castaño; Amaya Hilario
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.